| Literature DB >> 26151705 |
Kshitij Gupta1, Kirill A Afonin2, Mathias Viard3, Virginia Herrero4, Wojciech Kasprzak5, Ioannis Kagiampakis6, Taejin Kim7, Alexey Y Koyfman8, Anu Puri7, Marissa Stepler7, Alison Sappe7, Vineet N KewalRamani7, Sarina Grinberg4, Charles Linder9, Eliahu Heldman10, Robert Blumenthal7, Bruce A Shapiro11.
Abstract
In this study we have investigated a new class of cationic lipids--"bolaamphiphiles" or "bolas"--for their ability to efficiently deliver small interfering RNAs (siRNAs) to cancer cells. The bolas of this study consist of a hydrophobic chain with one or more positively charged head groups at each end. Recently, we reported that micelles of the bolas GLH-19 and GLH-20 (derived from vernonia oil) efficiently deliver siRNAs, while having relatively low toxicities in vitro and in vivo. Our previous studies validated that; bolaamphiphiles can be designed to vary the magnitude of siRNA shielding, its delivery, and its subsequent release. To further understand the structural features of bolas critical for siRNAs delivery, new structurally related bolas (GLH-58 and GLH-60) were designed and synthesized from jojoba oil. Both bolas have similar hydrophobic domains and contain either one, in GLH-58, or two, in GLH-60 positively charged head groups at each end of the hydrophobic core. We have computationally predicted and experimentally validated that GLH-58 formed more stable nano sized micelles than GLH-60 and performed significantly better in comparison to GLH-60 for siRNA delivery. GLH-58/siRNA complexes demonstrated better efficiency in silencing the expression of the GFP gene in human breast cancer cells at concentrations of 5μg/mL, well below the toxic dose. Moreover, delivery of multiple different siRNAs targeting the HIV genome demonstrated further inhibition of virus production. Published by Elsevier B.V.Entities:
Keywords: Bolaamphiphiles; Cryo-EM; FRET; Molecular dynamics simulations; RNAi induced gene silencing; siRNA drug delivery
Mesh:
Substances:
Year: 2015 PMID: 26151705 PMCID: PMC4699870 DOI: 10.1016/j.jconrel.2015.06.041
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 9.776